A Case of Disseminated and Fulminant Plasmacytomas That Developed during Bortezomib Treatment

Multiple myeloma is an incurable and slow growing plasma cell neoplasm. The introduction of new drugs has increased the number of treatment options. Bortezomib, the first-in-class proteasome inhibitor, has been shown to have a significant antitumor activity in the treatment of relapse/refractory pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Bae, Soo-Young, Ahn, Jae-Sook, Yang, Deok-Hwan, Kim, Yeo-Kyeoung, Min, Jung-Joon, Song, Ho-Chun, Bom, Hee-Seung, Jeong, Yong Yeon, Kim, Hyeoung-Joon, Lee, Je-Jung
Formato: Texto
Lenguaje:English
Publicado: S. Karger AG 2011
Materias:
Published: February 2011
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3072187/
https://www.ncbi.nlm.nih.gov/pubmed/21475598
http://dx.doi.org/10.1159/000324920

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3072187/
https://www.ncbi.nlm.nih.gov/pubmed/21475598
http://dx.doi.org/10.1159/000324920

Ejemplares similares